 |
|
Take heart, it's all good news
March 30, 2005New evidence uncovered by researchers in Tayside and Bristol has shown wider benefits of cholesterol lowering drugs for large sections of the public, including women and the elderly.
Researchers have told us for years that cholesterol lowering drugs that lower blood fat levels provide large benefits to those who participated in clinical trails. However, the effects of these drugs were only really applicable to the sorts of carefully selected patients who actually participated in those trials.
The new evidence now available from a combined Tayside and Bristol research project, published this week in the British Medical Journal, shows that these drugs provide benefits of at least an equal level of benefit to patients groups who were excluded from the clinical trial - the old, the very old, women and those who are unfortunate enough to suffer from a number of other pre-existing diseases.
This is really good news for those patients because it has often been found that when taken in general use rather than in clinical trials, medicines do not seem to work as well. This can be because the people in the trials have been selected to be those that will benefit most or those that will have the fewest side effects.
Professor Tom MacDonald, of the University of Dundee, the lead author of the research said "The results of this study are very important as we know now that all patients get similar benefits to those who were in the original studies. It is also good news for the research technique of studying routinely collected data (in an anonymous way of course) of many NHS patients and importantly using quality NHS data as well as being able to bring together data from a range of NHS sources. Such research has important implications in ensuring a good risk/benefit ratio for all medicines."
The study looked at the data of nearly 5000 patients who were discharged from hospital following a heart attack over an 8 year period. The researchers checked to see the level of cardiovascular outcomes or deaths occurring in these patients and whether they had been treated with statin (the name for a particular type of drug class that lowers cholesterol). Those treated with statins had lower rates of cardiovascular outcomes and death compared to those not treated and the level of benefit were similar across all patient groups. Additionally this research study included a far greater proportion of women and showed they also had good results.
This research is part of an on-going series of projects being undertaken by university researchers in conjunction with the NHS in Tayside that uses advanced methods to develop anonymous clinical information. This ensures that the researchers can make the maximum use of such information whilst ensuring confidentiality. Such research helps to ensure that the treatments available on the NHS have the right balance of benefit and risk.
University of Dundee
This is really good news for those patients because it has often been found that when taken in general use rather than in clinical trials, medicines do not seem to work as well. This can be because the people in the trials have been selected to be those that will benefit most or those that will have the fewest side effects.
Professor Tom MacDonald, of the University of Dundee, the lead author of the research said "The results of this study are very important as we know now that all patients get similar benefits to those who were in the original studies. It is also good news for the research technique of studying routinely collected data (in an anonymous way of course) of many NHS patients and importantly using quality NHS data as well as being able to bring together data from a range of NHS sources. Such research has important implications in ensuring a good risk/benefit ratio for all medicines."
The study looked at the data of nearly 5000 patients who were discharged from hospital following a heart attack over an 8 year period. The researchers checked to see the level of cardiovascular outcomes or deaths occurring in these patients and whether they had been treated with statin (the name for a particular type of drug class that lowers cholesterol). Those treated with statins had lower rates of cardiovascular outcomes and death compared to those not treated and the level of benefit were similar across all patient groups. Additionally this research study included a far greater proportion of women and showed they also had good results.
This research is part of an on-going series of projects being undertaken by university researchers in conjunction with the NHS in Tayside that uses advanced methods to develop anonymous clinical information. This ensures that the researchers can make the maximum use of such information whilst ensuring confidentiality. Such research helps to ensure that the treatments available on the NHS have the right balance of benefit and risk.
University of Dundee
Cholesterol Current Events and Cholesterol News RSSFree e-samples of prescription drugs: At what cost?
Search the Internet to learn about your asthma, high cholesterol or other common disorder, and odds are you'll be directed to a pharmaceutical company-sponsored Web homepage.
Genetic analysis helps dissect molecular basis of cardiovascular disease
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.
New understanding about mechanism for cell death after stroke leads to possible therapy
Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage.
Dispensing prescription drugs in 3-month supplies reduces drug costs by a third
Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Pivotal study for PSD502 -- the first potential treatment for premature ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.
Heart and bone damage from low vitamin D tied to declines in sex hormones
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.
Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing.
More Cholesterol Current Events and Cholesterol News Articles
 |
Cholesterol Down: Ten Simple Steps to Lower Your Cholesterol in Four Weeks--Without Prescription Drugs by Janet Brill (Author) Take Control of Your Cholesterol— Without Drugs If you are one of the nearly 100 million Americans struggling with high cholesterol, then Dr. Janet Brill offers you a revolutionary new plan for taking control of your health—without the risks of statin drugs. With Dr. Brill’s breakthrough Cholesterol Down Plan, you simply add nine “miracle foods” to your regular diet and thirty minutes of walking to your daily routine. That’s all. This straightforward and easy-to-follow program can lower your LDL (“bad”) cholesterol by as much as 47 percent in just four weeks. Cholesterol Down explains Dr. Brill’s ten-point plan as well as the science behind it. You’ll learn how each miracle food affects LDL cholesterol and how the foods work together for maximum effect,... |
 |
Benecol Smart Chews, Caramel, 120-Count Soft Chews by Benecol #review { width: auto; margin: auto; padding: 0px 10px 10px 10px; } .caption { font-family: Verdana, Helvetica neue, Arial, serif; font-size: 10px; font-weight: bold; font-style: italic; } .headline { font-family: Verdana, Helvetica neue, Arial, serif; font-size: 13px; font-weight: bold; color: #008000; } ul.indent { list-style: inside disc; text-indent: -15px; } #section-head { width: auto; margin: 0px 0px 10px 0px; padding-top: 5px; padding-bottom: 5px; padding-left: 5px; background: #c4df9b; color: #008000; font-size: 16px; font-weight: bold; font-family: Verdana, Helvetica neue, Arial, sans-serif; border-bottom: 2px solid #008000; border-top: 2px solid #008000; } #section-break { margin-top: 40px; clear: both; } th.reviewclass {... |
 |
Eating for Lower Cholesterol: A Balanced Approach to Heart Health with Recipes Everyone Will Love by Catherine Jones (Author), Elaine Trujillo MS RD CNSD MS RD CNSD (Contributor) Eating for lower cholesterol has never been easier, or tastier. High cholesterol is directly associated with heart disease. New national guidelines for healthy cholesterol levels, recently revised to be more stringent, mean millions of Americans need to bring their levels down. While doctors fill out millions of prescriptions for cholesterol-lowering drugs, diet remains a proven, supremely effective way to reduce cholesterol. Now, professional cookbook author and health-conscious chef, Catherine Jones, and one of the nation’s leading nutritionists, Elaine B. Trujillo, offer a wealth of cutting-edge information along with a collection of delicious recipes to help lower your cholesterol levels. Key features of this authoritative, information-packed book include: • An... |
 |
Controlling Cholesterol For Dummies (For Dummies (Health & Fitness)) by Carol Ann Rinzler (Author), Martin W. Graf MD (Contributor) Need to get your cholesterol in check? You’ll find the latest information about cholesterol, including treatments, drug information, and dietary advice, in Controlling Cholesterol For Dummies, 2nd Edition, an easy-to-understand guide to cholesterol control. You’ll learn how to lower your numbers and maintain healthy cholesterol levels. You’ll also find out how to eat and exercise properly, use vitamins and supplements, and quit unhealthy habits. You’ll find out cholesterol’s positive functions and why too much can be a bad thing. You can also assess your cholesterol risk by taking your age, sex, ethnicity, and family history into consideration. Find out what you need to ask your doctor about stress tests, ECBT, and angiograms to check for plaque buildup. Design a... |
 |
Twinlab Cholesterol Success, Tablets, 120 tablets by Twinlab Dietary supplement. Clinically proven. Reduces cholesterol up to 24%. Now 40% smaller tablets - easier to swallow. All natural. Clinical research has proven that plant sterols and stanols like those found in the Cholesterol Success ingredient CardioCare, may reduce LDL cholesterol (often described as the bad cholesterol) up to 24% when 1.7 g per day are consumed as part of a healthy diet (Jones et al., AM. J. Clin. Nutr. 1999, 69: 1144-1150.) We are confident our product name does not overstate our promise. Combining Cholesterol Success with proper diet & exercise will help you to achieve success in your fight to improve your cholesterol health. Products containing at least 0.4 g per serving of plant sterols, eaten twice a day with meals for a daily intake of at least 0.8 g, as part of a... |
 |
The Great Cholesterol Con by Anthony Colpo (Author) heart disease, cholesterol, saturated fat, fat, |
 |
The New 8-Week Cholesterol Cure: The Ultimate Program for Preventing Heart Disease by Robert E. Kowalski (Author) The groundbreaking cholesterol-lowering program . . . now even more effective! Robert Kowalski's personal story is legendary. By the age of forty-one, he had suffered a heart attack and had undergone two coronary bypass surgeries. A traditional dietary approach to lowering his cholesterol failed dismally, and faced with the unpleasant alternative of a lifetime on medication, he created a program that proved astonishingly effective for him -- and legions of others worldwide who used it. Today Kowalski has beaten heart disease, lives an unlimited and vigorous lifestyle, and uses no prescription drugs. Now, with new information about risk factors, exercise, and supplements, The New 8-Week Cholesterol Cure is even more powerful in fighting heart disease. It includes: ... |
 |
CardioChek Cholesterol Test Strips, 3-Count Containers (Pack of 2) by CardioChek The CardioChek Cholesterol Test Strip provides a quantitative measurement of total cholesterol in whole blood. Cholesterol is an important substance used by the body. Elevated cholesterol is a risk factor for coronary heart disease. A memo chip is provided with each package of test strips and must be properly inserted into the CardioChek meter before performing a test. After the test strip is inserted into the meter and blood sample is applied to the test strip, test results are displayed in about 1 minute. |
 |
50 Ways to Lower Cholesterol by Mary McGowan (Author) Because diet, weight, exercise, and genetics determine cholesterol levels, the treatment of a cholesterol disorder requires a multifaceted approach. 50 Ways to Lower Your Cholesterol provides you with a proven plan to lower cholesterol. Here, the author delivers sound advice, 50 workable solutions, explanations of both "good" and "bad" cholesterol, and the latest information on key treatments--including LDL-apheresis, superstatins, and cholesterol ester transfer protein inhibitors--medication, and supplements. |
 |
The Great Cholesterol Con: The Truth About What Really Causes Heart Disease and How to Avoid It by Dr. Malcolm Kendrick (Author) Statins are the so-called "wonder drugs" widely prescribed to lower blood cholesterol levels that claim to offer unparalleled protection against heart disease. Many experts claim that they are completely safe and that they are also capable of preventing a whole series of other conditions. This groundbreaking study exposes the truth behind the hype surrounding statins and reveals a number of crucial facts, including that high cholesterol levels do not cause heart disease; that high-fat diets—saturated or otherwise—do not affect blood cholesterol levels; and that for most men and all women the benefits offered by statins are negligible at best. Other data is also provided that shows that statins have many more side affects than is often acknowledged. This... |
| © 2009 BrightSurf.com |